At the Beverly Hills Cancer Center, we recognize the importance of bringing the most advanced cancer care to patients. Our cancer research program unites clinical care and ground-breaking research in order to achieve this goal at our private Los Angeles treatment facility.
By providing access to groundbreaking clinical trials, the Beverly Hills Cancer Center offers patients the opportunity to participate in the most advanced cancer treatments currently in development.
Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients
The advances in cancer care over the last decades are the result of research through clinical trials, which have resulted in many new treatment and prevention options for cancer care. Clinical trials are studies conducted to evaluate the effectiveness of innovative therapies for cancer patients.
For some patients, participation in trials represents a great opportunity for disease management. Currently available cancer drugs, in particular the most recently developed, were once only available in clinical trials.
At our Southern California Cancer Care Center, we believe that every person with cancer deserves to have access to the finest and most groundbreaking therapies available. Our physicians work closely with patients to continuously assess the potential benefit to participating in a clinical trial. Dr. O'Day and the Beverly Hills Cancer Center physicians closely monitor advancements in cancer research in order to identify and access the most cutting edge treatments in development.
A clinical trial is a research study designed to evaluate potential new treatment options. These studies are the result of a long and complex research process that takes many years. Clinical trials test the safety and effectiveness of new or modified cancer drugs, new drug doses, unique approaches to surgery or radiation therapy, and varied combinations of treatments. Clinical trials play a central role in improving the treatment of medical conditions because they lead to higher standards of care. In the United States, all new cancer treatment products must proceed through a formal clinical trials evaluation process to ensure they are safe and demonstrate benefit for cancer patients.
By participating in clinical trials, our patients have access to the most ground-breaking therapies.
The development process for new cancer treatments occur in four phases. Each phase serves a specific purpose in determining information about the potential new treatment. See the descriptions below for each of the four phases.
Phase I trials involve a small number of patients for whom the new treatment may provide a benefit over existing treatments that have failed. The primary goals of this phase are to determine the drug's activity, appropriate treatment dosing, and any specific side effects related to the drug. Upon successful completion of Phase I, the treatment option will move into Phase II.
Phase II trials are designed to determine effectiveness of the new therapy in treating a specific cancer patient population based on information that was generated in Phase I. Phase II trials involve a higher number of patients and therapies shown to be effective may become standard treatment or be further evaluated in Phase III.
Phase III trials compare the new treatment therapy with the currently existing standard therapy in order to determine proof of effectiveness. Phase III trials require a large number of patients to measure the validity of the treatment results. Oftentimes, a number of cancer centers will participate in Phase III trials to ensure the necessary number of patients are treated in the trial.
After a therapy has been approved for treatment, it will undergo continued evaluation of its effectiveness and monitoring of side effects as well as evaluating the therapy's potential in additional types of cancer.
Clinical trials are designed to test treatments under very specific, highly monitored and ethical guidelines. Each clinical trial is designed in a formal manner to explain what the trial will do, how it will be conducted, who may participate and how and when the participants will be evaluated. All clinical trials are formally reviewed by an independent Institutional Review Board (IRB) in order to confirm trial design and ensure patient safety.
Clinical trials evaluating cancer treatments available for participation at the Beverly Hills Cancer Center adhere to the strictest policies and procedures necessary and required in order to ensure the highest possible patient safety and treatment standards.
The objective of clinical trials is to test new therapies in cancer patients. Patients participate in clinical trials for the potential to benefit from a new drug or treatment procedure. In addition, clinical trials represent an opportunity to contribute to the advancement of cancer treatment and benefit other patients.
Although the field of cancer research has experienced progress in recent years, there remains significant need and opportunity to further advance treatments and ultimately develop cures for cancer. Many organizations, especially biopharmaceutical companies, will continue to identify new treatments for clinical trial development. As a result, patient and physician demand for and participation in clinical trials will grow, and the Beverly Hills Cancer Center will continue to serve as leader in cancer research.
To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or Click the link below to access our Online Appointment Request
Book An Appointment© Beverly Hills Cancer Center. All Rights Reserved. Web Design & Internet Marketing by Studio III
